Homology Medicines
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch FIXX and buy or sell other stocks, ETFs, and their options commission-free!About FIXX
Q32 Bio, Inc. operates as a clinical stage biotechnology company developing biologic therapeutics targeting potent regulators of the innate and adaptive immune systems to re-balance immunity in autoimmune and inflammatory diseases. It focuses on the IL-7 / TSLP receptor pathways and complement system, addressing immune dysregulation to help patients take back control of their lives.
CEOJodie P. Morrison
CEOJodie P. Morrison
Employees42
Employees42
HeadquartersWaltham, Massachusetts
HeadquartersWaltham, Massachusetts
Founded
Founded
Employees42
Employees42
FIXX Key Statistics
Market cap35.44M
Market cap35.44M
Price-Earnings ratio-0.83
Price-Earnings ratio-0.83
Dividend yield—
Dividend yield—
Average volume445.20K
Average volume445.20K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$6.37
52 Week high$6.37
52 Week low$1.35
52 Week low$1.35
Stock Snapshot
With a market cap of 35.44M, Homology Medicines(FIXX) trades at $2.88. The stock has a price-to-earnings ratio of -0.83.
During the trading day, Homology Medicines(FIXX) stock saw an opening price of —, a peak of —, and a bottom of —.
Trading volume for Homology Medicines(FIXX) stock has reached 0, versus its average volume of 445.2K.
Over the past 52 weeks, Homology Medicines(FIXX) stock has traded between a high of $6.37 and a low of $1.35.
Over the past 52 weeks, Homology Medicines(FIXX) stock has traded between a high of $6.37 and a low of $1.35.
People also own
Based on the portfolios of people who own FIXX. This list is generated using Robinhood data, and it’s not a recommendation.